Australia-wide dispatch

Quantified
Peptides
Cartalax 20mg — research peptide, lyophilised powder in a glass vial, supplied by Quantified Peptides, Sydney, Australia. For in-vitro research use only.

Peptides

Cartalax

Cartalax (Ala-Glu-Asp-Gly), russian peptide bioregulator research. Supplied as a lyophilised powder in 20mg vials.

Supplied as lyophilised powder in a 20mg specification. Storage: -20°C · Keep dry, avoid light. Dispatched from Sydney, Australia-wide.

Product information

About Cartalax

Cartalax (Ala-Glu-Asp-Gly)

Research background as published in the scientific literature. Supplied for in-vitro laboratory research only; nothing here is a claim about use in humans or animals.

Cartalax (Ala-Glu-Asp-Gly) is a synthetic tetrapeptide studied for its effects on cartilage tissue biology. It is part of a class of short regulatory peptides developed in Russian research programmes investigating peptide bioregulators.

Research has focused on its effects on chondrocyte proliferation and gene expression in cartilage tissue models. Studies have examined its potential role in supporting cartilage matrix integrity and cellular function in age-related research contexts.

Type
Short peptide — tetrapeptide
Research Areas
Cartilage tissue, chondrocyte biology, ageing
Sequence
Ala-Glu-Asp-Gly
Research Area
Cartilage, chondrocyte biology
Origin
Russian peptide bioregulator research
Key Markers
Collagen II, Aggrecan
Research Models
Chondrocyte cell culture
Research Era
1970s–present (Khavinson)
  1. 01Chondrocyte ProliferationCartalax research has examined its effects on chondrocyte cell culture models, with studies investigating peptide-induced changes in cell proliferation rates and extracellular matrix protein expression in cartilage tissue.
  2. 02Gene Expression ModulationLaboratory studies have explored Cartalax's effects on gene expression in cartilage cells, with research examining changes in collagen type II, aggrecan, and other cartilage-specific marker expression.
  3. 03CytoprotectionResearch has investigated Cartalax's potential cytoprotective effects in cartilage cell models subjected to oxidative stress, examining cell viability and mitochondrial function parameters.

References

  1. 1Khavinson VK et al. Peptide regulation of gene expression and protein synthesis in chondrocytes. Bull Exp Biol Med. 2009;148(2):332-335.
  2. 2Khavinson VK. Peptides and ageing. Neuro Endocrinol Lett. 2002;23(Suppl 3):11-144.
  3. 3PubMed: pubmed.ncbi.nlm.nih.gov/?term=Cartalax+peptide
  4. 4Anisimov VN et al. Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence. Neuro Endocrinol Lett. 2003.

Also in this range.

Compounds the supplier files alongside this one.

View the range
KPV 10mg — research peptide, lyophilised powder in a glass vial, supplied by Quantified Peptides, Sydney, Australia. For in-vitro research use only.

$60